<DOC>
	<DOCNO>NCT02139020</DOCNO>
	<brief_summary>The investigator collect plasma sample baseline , treatment , progression .</brief_summary>
	<brief_title>Collection Plasma Samples Squamous Cell Carcinoma Head Neck Patients</brief_title>
	<detailed_description>In study , investigator collect plasma sample baseline , treatment , progression . This plasma bank use study potential value biomarkers predict treatment activity resistance cetuximab target agent</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>patient treat radiation therapy cetuximab accord Bonner et al patient treat cetuximab combination chemotherapy accord Vermorken et al . patient treat molecular target agent part clinical study patient another type head neck cancer patient non treat targeted therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Targeted therapy</keyword>
	<keyword>Plasma sample</keyword>
</DOC>